About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Penn Medicine Abramson Cancer Center
11th Neuro-Oncology Brain Tumor Symposium
2024 Updates in Care of the Hematologic Malignancies Patient
11th Focus on Leukemia, Lymphoma, Myeloma & Cellular Therapies
18th Wallace H. Clark Jr, MD Lectureship in Cutaneous Oncology and Melanoma Symposium
2023 Breast Cancer Highlights from International Medical Meetings: Fourth Annual Review
Cellicon Valley '23: The Future of Cell and Gene Therapies
Plenary Sessions
Concurrent Sessions
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium
Keynote and Plenary Sessions
Concurrent Sessions
2021 Updates in Care of the Hematologic Malignancies Patient
New Therapies and Current Patient Management of Lymphomas
Update on Patient Care Treatment Strategies in Leukemia
Controversies and Update for Patient Care in Multiple Myeloma
COVID-19
2020 Updates in Care of the Hematologic Malignancies Patient
New Therapies and Current Patient Management of Lymphomas
Update on Patient Care Treatment Strategies in Leukemia
Update in Blood and Marrow Transplantation and Cellular Therapy
Controversies and Update for Patient Care in Multiple Myeloma
2023
Updates in Oncology 2023 Philadelphia
2023 Updates in Care of The Hematologic Malignancies Patient
2022
Precision Surgery Intraoperative Molecular Imaging 2022
Sarcoma Management: Case-Based Discussion
Primary Hyperparathyroidism: A Multidisciplinary Case Review
Updates in Oncology 2022 Philadelphia
17th Wallace H. Clark Jr, MD Lectureship in Cutaneous Oncology and Melanoma Symposium
Annual Updates in Management of Thyroid Nodules
Management and Updates of Medullary Thyroid Cancer
2022 Breast Cancer Highlights From International Medical Meetings: Third Annual Review
A Multidisciplinary Approach to the Management of Melanoma & Cutaneous Carcinoma
2022 Updates in Care of the Hematologic Malignancies Patient
Updates on Colorectal Liver Metastases: A Multidisciplinary Approach
2021
4th Pituitary Update
Updates in Oncology 2021 Philadelphia: With Proceedings From International Medical Meetings
2021 Breast Cancer Highlights From International Medical Meetings: Second Annual Review
2020
COVID-19
2020 Updates in Oncology
2019
Immunotherapy
CNS
Webinars
Updates on Breast Care and Imaging During COVID: Vaccines, Screenings and Treatment
Updates in Pancreatic Cancer: A Team Approach to Complex Care
Updates in Management of Sarcoma: Local Treatment, Clinical Trials, and the Future of Sarcoma Care
Updates in Melanoma: Treatment, Clinical Trials and Coexisting with COVID-19
Updates in Thoracic Oncology: Treatment, Clinical Trials and Coexisting with COVID-19
Videos
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
V
Updates and Management of Medullary Thyroid Cancer: Genetic Testing for Patients With MTC
By
Penn Medicine Abramson Cancer Center
FEATURING
Virginia Livolsi
,
Katherine Nathanson
,
Lova L. Sun
,
Rachel Kelz
,
Susan Mandel
By
Penn Medicine Abramson Cancer Center
FEATURING
Virginia Livolsi
,
Katherine Nathanson
,
Lova L. Sun
,
Rachel Kelz
,
Susan Mandel
274 views
March 7, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Videos
09:30
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "The CLEVER Trial - Targeting Disseminated D…
Feat.
A. DeMichele
08:21
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Results from the QuANTUM-First Trial: Impact of allo-HCT i…
Feat.
A. Perl
09:47
Total Health
2023 ASCO® Direct Philadelphia: Phase 3 OVHIPEC-1 Trial Final Surviv…
Feat.
A. Smith
09:57
Total Health
2023 ASCO® Direct Philadelphia: Phase 3 SHAPE Trial - Radical vs. Si…
Feat.
A. Smith
10:29
Total Health
2023 ASCO® Direct Philadelphia: RUBY Trial Review - Dostarlimab + Ch…
Feat.
A. Smith
27:15
Total Health
Metastatic NSCLC Updates - 2023 ASCO® Direct Philadelphia
Feat.
S. Kazmi
09:27
Total Health
2023 ASCO® Direct Philadelphia: TRANSCEND CLL 004 Study - CLL/SLL Up…
Feat.
J. Svoboda
05:12
Total Health
2023 ASCO® Direct Philadelphia: Phase 3 ZUMA-7 Study - R/R DLBCL Upd…
Feat.
J. Svoboda
15:24
Total Health
2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates
Feat.
J. Svoboda
18:13
Total Health
Surgical Management of CRC Liver Metastases - 2023 ASCO® Direct Phil…
Feat.
R. Roses
20:46
Total Health
Perioperative Therapy for Early Stage NSCLC - Best of Lung 2023
Feat.
S. Kazmi
17:32
Total Health
ADAURA Trial Update: Osimertinib in Resected EGFRm NSCLC - Best of L…
Feat.
S. Kazmi
26:00
International Congress on Cancer Metastasis
Neoadjuvant Therapy for Resectable Melanoma
Feat.
G. Karakousis
05:46
Penn Medicine Abramson Cancer Center
Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…
Feat.
T. Karasic
05:27
Penn Medicine Abramson Cancer Center
Treatment Strategies in ALL: Journey to MRD Negativity
Feat.
C. Lai
16:19
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Exploring Immunotherapy Combinations for DDR-Deficient …
Feat.
K. Reiss Binder
09:17
Penn Medicine Abramson Cancer Center
The Role of Adjuvant Targeted Therapy in rNSCLC
Feat.
M. Marmarelis
18:34
Penn Medicine Abramson Cancer Center
2022 Delivery of Care for Cancer Patients During the COVID-19 Pandem…
Feat.
L. Schuchter
15:32
Penn Medicine Abramson Cancer Center
Update on Treatment of COVID-19 Infection for Cancer and Other Immun…
Feat.
K. Murphy
15:15
Penn Medicine Abramson Cancer Center
Update on Treatment and Prevention of COVID-19 in Cancer Patients
Feat.
A. Garfall
59:57
Penn Medicine Abramson Cancer Center
Penn Medicine Updates on the Advances in BRCA-Related Breast Cancer …
Feat.
S. Domchek
54:49
Penn Medicine Abramson Cancer Center
Updates and Management of Medullary Thyroid Cancer: Genetic Testing …
Feat.
V. Livolsi,
K. Nathanson,
L. L. Sun,
R. Kelz,
S. Mandel
12:44
Penn Medicine Abramson Cancer Center
Advances in Adjuvant Therapy in NSCLC
Feat.
C. Ciunci
08:56
Penn Medicine Abramson Cancer Center
47 y/o Male With Papillary Thyroid Cancer: How to Plan Surgery Strat…
Feat.
S. Mandel,
A. Chalian,
S. Swisher-Mcclure
09:21
Penn Medicine Abramson Cancer Center
47 y/o Male With Papillary Thyroid Cancer: Radioiodine-131 Planning …
Feat.
S. Mandel,
D. Pryma
12:13
Penn Medicine Abramson Cancer Center
47 y/o Male With High-Risk Thyroid Cancer: How Does Surveillance Wor…
Feat.
S. Mandel,
M. Brose
19:24
Penn Medicine Abramson Cancer Center
47 y/o Male With High-Risk Thyroid Cancer: What Is the Right Timing …
Feat.
S. Mandel,
M. Brose,
A. Chalian,
D. Pryma,
S. Swisher-Mcclure
07:27
Penn Medicine Abramson Cancer Center
Attributes of Low-Risk Thyroid Cancer: How to Predict Risk? AJCC TNM…
Feat.
S. Mandel
07:21
Penn Medicine Abramson Cancer Center
Low-Risk Thyroid Cancer Surgery Approach: What Are the Factors Influ…
Feat.
H. Wachtel
07:00
Penn Medicine Abramson Cancer Center
The Histopathology of Low-Risk Thyroid Cancer: How to Assess and Ide…
Feat.
J. Jalaly
04:13
Penn Medicine Abramson Cancer Center
Radioiodine Therapy for Low-Risk Thyroid Cancer: When Should I-131 T…
Feat.
B. Cooperberg
05:59
Penn Medicine Abramson Cancer Center
Management of Low-Risk Thyroid Cancer: Is There a Difference in Recu…
Feat.
S. Mandel
20:30
Penn Medicine Abramson Cancer Center
53 y/o Female With Papillary Thyroid Cancer, Two Suspicious R Latera…
Feat.
B. Cooperberg,
S. Mandel,
H. Wachtel
09:49
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on Early Local Therapy in mBC: Does ELT Impr…
Feat.
A. Mateo
11:35
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on HER2+ Ductal Carcinoma in Site: Does Tras…
Feat.
A. Mateo
07:01
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on mTNBC: Does the Addition of Pembro to Che…
Feat.
J. Matro
09:01
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on PARPi in mTNBC: Does Veliparib Improve Ch…
Feat.
J. Matro
05:41
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on Operable TNBC: What Is the Role of Adjuva…
Feat.
J. Matro
08:58
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on ET in MBC: Is Fulvestrant + Alpelisib Eff…
Feat.
P. Gor
09:35
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on Adjuvant ET in BC: In Pts Treated With an…
Feat.
P. Gor
13:49
Penn Medicine Abramson Cancer Center
Updates on HER2+ MBC: HER2CLIMB OS/PFS Data on Tucatinib Combo in Pa…
Feat.
H. Knollman
09:54
Penn Medicine Abramson Cancer Center
UPenn Updates on HER2+ EBC: CT De-Escalation Using F-PET, Adjuvant T…
Feat.
T. D'Entremont
05:16
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on Stage 2/3 HER2+ BC: Do Anthracyclines Imp…
Feat.
H. Knollman
09:42
Penn Medicine Abramson Cancer Center
UPenn 2020 ASCO Updates on Adjuvant ET in BC: Does the 70-Gene Signa…
Feat.
P. Gor
33:02
Penn Medicine
UPenn 2020 ASCO Breast Cancer Q&A: Preoperative Anthracyclines f…
Feat.
H. Knollman,
A. Mateo,
J. Matro,
T. D'Entremont
02:33
Penn Medicine Abramson Cancer Center
TumorGlow®: Illuminating Cancer Cells in the Operating Room
02:05
Penn Medicine Abramson Cancer Center
Advances in Precision Surgery with Penn Medicine’s TumorGlow™ Techno…
Feat.
S. Singhal
